TABLE 2.
Method | Sensitivity (%)
|
Specificity (%) for MSSA (n = 56) | ||
---|---|---|---|---|
All MRSA (n = 157) | Low-level MRSA (n = 29) | High-level MRSA (n = 128) | ||
Vitek 2 AST-P549 | 97.5 | 89.65 | 99.2 | 100 |
Disk diffusion | ||||
Cefoxitin | ||||
10 μg (Rosco) | 99.6 | 96.4 | 100 | 100 |
30 μg (Rosco) | 99.6 | 96.4 | 100 | 100 |
60 μg (Rosco) | 98.7 | 92.9 | 100 | 100 |
30 μg (Oxoid) | 98.7 | 92.9 | 100 | 100 |
Moxalactam 30 μg (Oxoid) | 98.7 | 92.9 | 100 | 100 |